Parts and ICRAFTs: Finding new immunotherapy targets.
Immunity
Authors | |
Abstract | CRISPR screens are widely utilized to identify genes that regulate immune function or mediate sensitivity of cancer cells to immune attack. In this issue of Immunity, Zeng et al. present a computational framework for uncovering gene targets with dual function in both cancer and immune cells and nominate TNFAIP3 as a synergistic target whose ablation strongly elicits an antitumor response. |
Year of Publication | 2025
|
Journal | Immunity
|
Volume | 58
|
Issue | 3
|
Pages | 529-531
|
Date Published | 03/2025
|
ISSN | 1097-4180
|
DOI | 10.1016/j.immuni.2025.02.016
|
PubMed ID | 40073844
|
Links |